This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Amgen Inc.. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Alisa Golightly: Innovator in Pharmaceutical Chemistry
Introduction
Alisa Golightly is a prominent inventor based in Tranent, GB. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds. Her work has led to advancements that may improve therapeutic options for patients.
Latest Patents
Alisa holds a patent for "Salts and crystal forms of omecamtiv mecarbil." This patent includes free base crystalline forms, crystalline salts, and amorphous salts of omecamtiv mecarbil. This innovation is crucial for enhancing the efficacy and stability of the compound in pharmaceutical applications. She has 1 patent to her name.
Career Highlights
Throughout her career, Alisa has demonstrated a strong commitment to research and development in the pharmaceutical industry. Her work at Amgen Inc. has positioned her as a key player in the innovation of new therapeutic agents.
Collaborations
Alisa has collaborated with notable colleagues, including Henry Morrison and Sheng Cui. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.
Conclusion
Alisa Golightly's contributions to pharmaceutical chemistry exemplify the impact of innovative thinking in the development of new treatments. Her patent on omecamtiv mecarbil showcases her dedication to advancing medical science.